Articles Tagged With: HIV
-
An Investigational Vaginal Film Could One Day Prevent Pregnancy, HIV, Herpes
Researchers are studying a novel contraceptive delivery system, which uses a vaginal film to produce antibodies to sperm. The same film also could be developed to protect against HIV infection and herpes. -
40 years of HIV: From Fear and Stigma to Effective Treatment
A constantly mutating retrovirus that attacks the immune system directly, human immunodeficiency virus was isolated as the cause of acquired immunodeficiency syndrome in 1984. There was initial optimism that a vaccine would be forthcoming, but it was not to be.
-
Infectious Disease Alert Updates
Sexual Distancing vs. Access to Care During COVID; Zoonosis in Federal Service Dogs; Echinococcus in Saskatchewan -
Adolescents with HIV Experience High Rates of Unintended Pregnancies
Adolescents living with HIV in the United States are among the groups with the highest rates of adolescent pregnancy. The latest research shows these pregnancies are likely to be unintended. Researchers found 83.6% of pregnancies among HIV-infected adolescents were unintended. Among adult women with HIV in this study, 68.7% experienced unintended pregnancy.
-
HIV Management During Pregnancy
Human immunodeficiency virus (HIV) infection during pregnancy carries a significant burden to healthcare systems, and continues to be of significant public health concern.
-
Bloodborne Pathogens
In the acute care setting, clinicians may be confronted with a child who has had a nonoccupational blood and/or body fluid exposure. Being prepared with a focused approach and the ability to identify the multiple factors that may adjust the risk of contracting bloodborne pathogens is valuable in such exposures. The authors provide a focused approach to nonoccupational blood and/or body fluid exposure, as well as a discussion of each of the bloodborne pathogens.
-
Surge of HIV Patients Present to EDs, Leaders Call for Expanded Screening
Investigators discovered a more than twofold increase in cases of acute HIV during the COVID-19 pandemic as part of an ED-based screening program at UChicago Medicine. The cause of the increase remains unknown, but it underscores the importance of screening despite the fact the pandemic has strained all resources.
-
Cabotegravir Extended-Release and Rilpivirine Injectable Suspension (Cabenuva) and Cabotegravir Tablets (Vocabria)
Cabotegravir/rilpivirine (CAB/RPV) should be prescribed to treat HIV-1-infected adults. This combination should replace the current antiretroviral (ARV) regimen in those who are virologically suppressed (HIV-1 RNA < 50 copies/mL) on a stable regimen with no history of treatment failure and no known or suspected resistance to ether CAB or RPV.
-
Patients with HIV More Likely to Take Medication Described as ‘Cure’
Clinicians and researchers should improve informed consent so that people living with HIV have a realistic understanding of treatment options and possible outcomes.
-
Fostemsavir Extended-Release Tablets (Rukobia)
Fostemsavir is indicated, with other antiretrovirals, to treat HIV-1 infections in heavily treatment-experienced adults with multidrug-resistant HIV-1 infections who are failing current regimens.